170 related articles for article (PubMed ID: 30967788)
41. Ion channel mechanisms related to sudden cardiac death in phenotype-negative long-QT syndrome genotype-phenotype correlations of the KCNQ1(S349W) mutation.
Horr S; Goldenberg I; Moss AJ; O-Uchi J; Barsheshet A; Connelly H; Gray DA; Zareba W; Lopes CM
J Cardiovasc Electrophysiol; 2011 Feb; 22(2):193-200. PubMed ID: 20662986
[TBL] [Abstract][Full Text] [Related]
42. Characterization of a Chinese KCNQ1 mutation (R259H) that shortens repolarization and causes short QT syndrome 2.
Wu ZJ; Huang Y; Fu YC; Zhao XJ; Zhu C; Zhang Y; Xu B; Zhu QL; Li Y
J Geriatr Cardiol; 2015 Jul; 12(4):394-401. PubMed ID: 26346102
[TBL] [Abstract][Full Text] [Related]
43. A dual mechanism for I(Ks) current reduction by the pathogenic mutation KCNQ1-S277L.
Chen J; Weber M; Um SY; Walsh CA; Tang Y; McDonald TV
Pacing Clin Electrophysiol; 2011 Dec; 34(12):1652-64. PubMed ID: 21895724
[TBL] [Abstract][Full Text] [Related]
44. Long QT syndrome-associated mutations in KCNQ1 and KCNE1 subunits disrupt normal endosomal recycling of IKs channels.
Seebohm G; Strutz-Seebohm N; Ureche ON; Henrion U; Baltaev R; Mack AF; Korniychuk G; Steinke K; Tapken D; Pfeufer A; Kääb S; Bucci C; Attali B; Merot J; Tavare JM; Hoppe UC; Sanguinetti MC; Lang F
Circ Res; 2008 Dec; 103(12):1451-7. PubMed ID: 19008479
[TBL] [Abstract][Full Text] [Related]
45. Cellular mechanisms underlying the increased disease severity seen for patients with long QT syndrome caused by compound mutations in KCNQ1.
Harmer SC; Mohal JS; Royal AA; McKenna WJ; Lambiase PD; Tinker A
Biochem J; 2014 Aug; 462(1):133-42. PubMed ID: 24912595
[TBL] [Abstract][Full Text] [Related]
46. Long QT 1 mutation KCNQ1A344V increases local anesthetic sensitivity of the slowly activating delayed rectifier potassium current.
Siebrands CC; Binder S; Eckhoff U; Schmitt N; Friederich P
Anesthesiology; 2006 Sep; 105(3):511-20. PubMed ID: 16931984
[TBL] [Abstract][Full Text] [Related]
47. Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.
Deschênes D; Acharfi S; Pouliot V; Hegele R; Krahn A; Daleau P; Chahine M
Can J Physiol Pharmacol; 2003 Feb; 81(2):129-34. PubMed ID: 12710526
[TBL] [Abstract][Full Text] [Related]
48. Pro-arrhythmogenic effects of the S140G KCNQ1 mutation in human atrial fibrillation - insights from modelling.
Kharche S; Adeniran I; Stott J; Law P; Boyett MR; Hancox JC; Zhang H
J Physiol; 2012 Sep; 590(18):4501-14. PubMed ID: 22508963
[TBL] [Abstract][Full Text] [Related]
49. Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
Moretti A; Bellin M; Welling A; Jung CB; Lam JT; Bott-Flügel L; Dorn T; Goedel A; Höhnke C; Hofmann F; Seyfarth M; Sinnecker D; Schömig A; Laugwitz KL
N Engl J Med; 2010 Oct; 363(15):1397-409. PubMed ID: 20660394
[TBL] [Abstract][Full Text] [Related]
50. Proarrhythmic consequences of a KCNQ1 AKAP-binding domain mutation: computational models of whole cells and heterogeneous tissue.
Saucerman JJ; Healy SN; Belik ME; Puglisi JL; McCulloch AD
Circ Res; 2004 Dec; 95(12):1216-24. PubMed ID: 15528464
[TBL] [Abstract][Full Text] [Related]
51. New KCNQ1 mutations leading to haploinsufficiency in a general population; Defective trafficking of a KvLQT1 mutant.
Gouas L; Bellocq C; Berthet M; Potet F; Demolombe S; Forhan A; Lescasse R; Simon F; Balkau B; Denjoy I; Hainque B; Baró I; Guicheney P;
Cardiovasc Res; 2004 Jul; 63(1):60-8. PubMed ID: 15194462
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms by which atrial fibrillation-associated mutations in the S1 domain of KCNQ1 slow deactivation of IKs channels.
Restier L; Cheng L; Sanguinetti MC
J Physiol; 2008 Sep; 586(17):4179-91. PubMed ID: 18599533
[TBL] [Abstract][Full Text] [Related]
53. Pro-arrhythmogenic Effects of the V141M KCNQ1 Mutation in Short QT Syndrome and Its Potential Therapeutic Targets: Insights from Modeling.
Lee HC; Rudy Y; Liang H; Chen CC; Luo CH; Sheu SH; Cui J
J Med Biol Eng; 2017 Oct; 37(5):780-789. PubMed ID: 29213224
[TBL] [Abstract][Full Text] [Related]
54. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.
Swan H; Viitasalo M; Piippo K; Laitinen P; Kontula K; Toivonen L
J Am Coll Cardiol; 1999 Sep; 34(3):823-9. PubMed ID: 10483966
[TBL] [Abstract][Full Text] [Related]
55. Proof of concept for monoclonal antibody therapy in a cellular model of acquired long QT syndrome type 3.
Kis L; Li J
Am J Physiol Heart Circ Physiol; 2024 Jan; 326(1):H89-H95. PubMed ID: 37947435
[TBL] [Abstract][Full Text] [Related]
56. A molecular mechanism for adrenergic-induced long QT syndrome.
Wu J; Naiki N; Ding WG; Ohno S; Kato K; Zang WJ; Delisle BP; Matsuura H; Horie M
J Am Coll Cardiol; 2014 Mar; 63(8):819-27. PubMed ID: 24184248
[TBL] [Abstract][Full Text] [Related]
57. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations.
Zhang X; Chen S; Zhang L; Liu M; Redfearn S; Bryant RM; Oberti C; Vincent GM; Wang QK
BMC Med Genet; 2008 Sep; 9():87. PubMed ID: 18808722
[TBL] [Abstract][Full Text] [Related]
58. KCNQ1 Antibodies for Immunotherapy of Long QT Syndrome Type 2.
Maguy A; Kucera JP; Wepfer JP; Forest V; Charpentier F; Li J
J Am Coll Cardiol; 2020 May; 75(17):2140-2152. PubMed ID: 32354382
[TBL] [Abstract][Full Text] [Related]
59. The role of abnormal trafficking of KCNE1 in long QT syndrome 5.
Harmer SC; Tinker A
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1074-6. PubMed ID: 17956282
[TBL] [Abstract][Full Text] [Related]
60. Influence of the KCNQ1 S140G Mutation on Human Ventricular Arrhythmogenesis and Pumping Performance: Simulation Study.
Jeong DU; Lim KM
Front Physiol; 2018; 9():926. PubMed ID: 30108508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
